Mega Genomics Ltd. has announced a suspension of trading in its shares on The Stock Exchange of Hong Kong Limited, effective from 9:00 a.m. on April 1, 2025. The halt was requested by the company and will continue until further notice. The suspension follows resumption guidance from the Stock Exchange, which includes conducting an independent forensic investigation into audit issues regarding revenue recognition and other financial matters.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mega Genomics Ltd. published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.